CEO LEADERSHIP SERIES
ASHTON TWEED'S CEO INTERVIEWS
September 1, 2012
USING VIRTUAL BIOTECHS TO MOVE DRUGS INTO DEVELOPMENT MORE EFFICIENTLY This year, Bridgewater, NJ-based Drais Pharmaceuticals, Inc., has launched a new business model. According to Drais […]
June 1, 2012
SUCCESS STRATEGIES FOR NEW DRUG DEVELOPMENT TODAY Originally published in Ashton Tweed Connection, Summer 2012 As the former President and CEO of Prism Pharmaceuticals, Dr. Warren […]
April 1, 2012
SUCCESSFULLY RIDING THE WAVE OF CHANGE IN PHARMA TODAY Originally published in Ashton Tweed Connection, April 2012 In 2005, Nick Spring cofounded Topaz Pharmaceuticals — a […]
February 1, 2012
THE RISKS AND REWARDS OF ENTREPRENEURSHIP Originally published in Ashton Tweed Connection, February 2012 What are the risks and rewards of entrepreneurship? That’s what we asked […]
September 1, 2011
Originally published in Ashton Tweed Connection, September 2011 As market conditions and the economy continue to improve, the specialty pharmaceutical industry is expected to grow substantially […]
ARE YOU A CEO INTERESTED IN JOINING OUR LEADERSHIP SERIES?
CONTACT US TO DISCUSS AN INTERVIEW:
Jordan Warshafsky
Partner, Ashton Tweed Ltd.
Email: JWarshafsky@ashtontweed.com
Phone: 610.725.0290 x441
Ashton Tweed, Ltd.
314 S. Henderson Rd.
Suite G370
King of Prussia, PA 19406